{"pmid":32340018,"title":"Coronavirus Disease 2019 in a Hemodialysis Patient.","text":["Coronavirus Disease 2019 in a Hemodialysis Patient.","There has been a global outbreak of the coronavirus disease 2019 (COVID-19) since December 2019. Here, we describe the case of a 49-year-old male undergoing maintenance hemodialysis (HD) who got infected with COVID-19 and our experience in performing HD for him. The patient's symptoms and lung imaging changes were atypical. However, his lymphocyte range decreased upon admission and the polymerase chain reaction of the pharyngeal swab for the -COVID-19 nucleic acid was positive. The patient developed respiratory failure and required mechanical ventilation 8 days after admission. In the end, he died from multiple organ dysfunction syndrome. The difficulties in diagnosis, infection control, and treatment of COVID-19 in maintenance HD patients are discussed in this report.","Blood Purif","Yuan, Hai","Guo, E","Gao, Zhao","Hu, Fengqi","Lu, Li","32340018"],"abstract":["There has been a global outbreak of the coronavirus disease 2019 (COVID-19) since December 2019. Here, we describe the case of a 49-year-old male undergoing maintenance hemodialysis (HD) who got infected with COVID-19 and our experience in performing HD for him. The patient's symptoms and lung imaging changes were atypical. However, his lymphocyte range decreased upon admission and the polymerase chain reaction of the pharyngeal swab for the -COVID-19 nucleic acid was positive. The patient developed respiratory failure and required mechanical ventilation 8 days after admission. In the end, he died from multiple organ dysfunction syndrome. The difficulties in diagnosis, infection control, and treatment of COVID-19 in maintenance HD patients are discussed in this report."],"journal":"Blood Purif","authors":["Yuan, Hai","Guo, E","Gao, Zhao","Hu, Fengqi","Lu, Li"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32340018","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1159/000507877","keywords":["coronavirus disease 19","end-stage renal disease","hemodialysis","severe acute respiratory syndrome-cov-2"],"topics":["Case Report"],"weight":1,"_version_":1665264685463633920,"score":8.574329,"similar":[{"pmid":32235119,"title":"Safeguarding the Maintenance Hemodialysis Patient Population during the Coronavirus Disease 19 Pandemic.","text":["Safeguarding the Maintenance Hemodialysis Patient Population during the Coronavirus Disease 19 Pandemic.","The World Health Organization has recognized the pandemic nature of the coronavirus disease 19 (COVID-19) outbreak. A large proportion of positive patients require hospitalization, while 5-6% of them may need more aggressive therapies in intensive care. Most governments have recommended social separation and severe measures of prevention of further spreading of the epidemic. Because hemodialysis (HD) patients need to access hospital and dialysis center facilities 3 times a week, this category of patients requires special attention. In this editorial, we tried to summarize the experience of our centers that hopefully may contribute to help other centers and colleagues that are facing the coming wave of the epidemic. Special algorithms for COVID-19 spreading in the dialysis population, recommendations for isolation and preventive measures in positive HD patients, and finally directions to manage logistics and personnel are reported. These recommendations should be considered neither universal nor absolute. Instead, they require local adjustments based on geographic location, cultural and social environments, and level of available resources.","Blood Purif","Meijers, Bjorn","Messa, Piergiorgio","Ronco, Claudio","32235119"],"abstract":["The World Health Organization has recognized the pandemic nature of the coronavirus disease 19 (COVID-19) outbreak. A large proportion of positive patients require hospitalization, while 5-6% of them may need more aggressive therapies in intensive care. Most governments have recommended social separation and severe measures of prevention of further spreading of the epidemic. Because hemodialysis (HD) patients need to access hospital and dialysis center facilities 3 times a week, this category of patients requires special attention. In this editorial, we tried to summarize the experience of our centers that hopefully may contribute to help other centers and colleagues that are facing the coming wave of the epidemic. Special algorithms for COVID-19 spreading in the dialysis population, recommendations for isolation and preventive measures in positive HD patients, and finally directions to manage logistics and personnel are reported. These recommendations should be considered neither universal nor absolute. Instead, they require local adjustments based on geographic location, cultural and social environments, and level of available resources."],"journal":"Blood Purif","authors":["Meijers, Bjorn","Messa, Piergiorgio","Ronco, Claudio"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32235119","week":"202014|Mar 30 - Apr 05","doi":"10.1159/000507537","keywords":["coronavirus","coronavirus disease 19","hemodialysis","prevention"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664638354212257792,"score":243.08301},{"pmid":32240718,"pmcid":"PMC7118604","title":"COVID-19 in Hemodialysis Patients: A Report of 5 Cases.","text":["COVID-19 in Hemodialysis Patients: A Report of 5 Cases.","In December 2019, an outbreak of coronavirus disease (COVID-19) due to the novel SARS-CoV-2 virus began in China and spread rapidly worldwide. It is unknown whether hemodialysis patients represent a distinct group of patients with certain characteristics that may make them susceptible to infection or severe disease. In this Case Report, we describe the clinical and epidemiological features of COVID-19 in 201 maintenance hemodialysis patients in Zhongnan Hospital of Wuhan university, including 5 maintenance hemodialysis patients who contracted COVID-19 disease. Of the 5 patients with COVID-19, one had a definite history of contact with an infected person. The age range of the patients was 47-67 years. Diarrhea (80%), fever (60%), and fatigue (60%) were the most common symptoms. Lymphopenia occurred in all patients.Chest computerized tomography (CT) scans showed ground glass opacity in the lungs of all patients. Up to February 13, 2020, none of the patients had developed severe complications (acute respiratory distress syndrome, shock, multiple organ dysfunction) or died.","Am J Kidney Dis","Wang, Rui","Liao, Cong","He, Hong","Hu, Chun","Wei, Zimeng","Hong, Zixi","Zhang, Chengjie","Liao, Meiyan","Shui, Hua","32240718"],"abstract":["In December 2019, an outbreak of coronavirus disease (COVID-19) due to the novel SARS-CoV-2 virus began in China and spread rapidly worldwide. It is unknown whether hemodialysis patients represent a distinct group of patients with certain characteristics that may make them susceptible to infection or severe disease. In this Case Report, we describe the clinical and epidemiological features of COVID-19 in 201 maintenance hemodialysis patients in Zhongnan Hospital of Wuhan university, including 5 maintenance hemodialysis patients who contracted COVID-19 disease. Of the 5 patients with COVID-19, one had a definite history of contact with an infected person. The age range of the patients was 47-67 years. Diarrhea (80%), fever (60%), and fatigue (60%) were the most common symptoms. Lymphopenia occurred in all patients.Chest computerized tomography (CT) scans showed ground glass opacity in the lungs of all patients. Up to February 13, 2020, none of the patients had developed severe complications (acute respiratory distress syndrome, shock, multiple organ dysfunction) or died."],"journal":"Am J Kidney Dis","authors":["Wang, Rui","Liao, Cong","He, Hong","Hu, Chun","Wei, Zimeng","Hong, Zixi","Zhang, Chengjie","Liao, Meiyan","Shui, Hua"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240718","week":"202014|Mar 30 - Apr 05","doi":"10.1053/j.ajkd.2020.03.009","keywords":["covid-19","hemodialysis","coronavirus"],"source":"PubMed","topics":["Case Report"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664638354115788800,"score":221.75075},{"pmid":32222713,"title":"A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease.","text":["A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease.","Novel coronavirus disease 2019 (COVID-19) is a highly infectious, rapidly spreading viral disease with an alarming case fatality rate up to 5%. The risk factors for severe presentations are concentrated in patients with chronic kidney disease, particularly patients with end-stage renal disease (ESRD) who are dialysis dependent. We report the first US case of a 56-year-old nondiabetic male with ESRD secondary to IgA nephropathy undergoing thrice-weekly maintenance hemodialysis for 3 years, who developed COVID-19 infection. He has hypertension controlled with angiotensin receptor blocker losartan 100 mg/day and coronary artery disease status-post stent placement. During the first 5 days of his febrile disease, he presented to an urgent care, 3 emergency rooms, 1 cardiology clinic, and 2 dialysis centers in California and Utah. During this interval, he reported nausea, vomiting, diarrhea, and low-grade fevers but was not suspected of COVID-19 infection until he developed respiratory symptoms and was admitted to the hospital. Imaging studies upon admission were consistent with bilateral interstitial pneumonia. He was placed in droplet-eye precautions while awaiting COVID-19 test results. Within the first 24 h, he deteriorated quickly and developed acute respiratory distress syndrome (ARDS), requiring intubation and increasing respiratory support. Losartan was withheld due to hypotension and septic shock. COVID-19 was reported positive on hospital day 3. He remained in critical condition being treated with hydroxychloroquine and tocilizumab in addition to the standard medical management for septic shock and ARDS. Our case is unique in its atypical initial presentation and highlights the importance of early testing.","Am J Nephrol","Ferrey, Antoney J","Choi, Grace","Hanna, Ramy M","Chang, Yongen","Tantisattamo, Ekamol","Ivaturi, Kaushik","Park, Elisa","Nguyen, Lawrence","Wang, Brian","Tonthat, Sam","Rhee, Connie M","Reddy, Uttam","Lau, Wei Ling","Huang, Susan S","Gohil, Shruti","Amin, Alpesh N","Hsieh, Lanny","Cheng, Timmy T","Lee, Richard A","Kalantar-Zadeh, Kamyar","32222713"],"abstract":["Novel coronavirus disease 2019 (COVID-19) is a highly infectious, rapidly spreading viral disease with an alarming case fatality rate up to 5%. The risk factors for severe presentations are concentrated in patients with chronic kidney disease, particularly patients with end-stage renal disease (ESRD) who are dialysis dependent. We report the first US case of a 56-year-old nondiabetic male with ESRD secondary to IgA nephropathy undergoing thrice-weekly maintenance hemodialysis for 3 years, who developed COVID-19 infection. He has hypertension controlled with angiotensin receptor blocker losartan 100 mg/day and coronary artery disease status-post stent placement. During the first 5 days of his febrile disease, he presented to an urgent care, 3 emergency rooms, 1 cardiology clinic, and 2 dialysis centers in California and Utah. During this interval, he reported nausea, vomiting, diarrhea, and low-grade fevers but was not suspected of COVID-19 infection until he developed respiratory symptoms and was admitted to the hospital. Imaging studies upon admission were consistent with bilateral interstitial pneumonia. He was placed in droplet-eye precautions while awaiting COVID-19 test results. Within the first 24 h, he deteriorated quickly and developed acute respiratory distress syndrome (ARDS), requiring intubation and increasing respiratory support. Losartan was withheld due to hypotension and septic shock. COVID-19 was reported positive on hospital day 3. He remained in critical condition being treated with hydroxychloroquine and tocilizumab in addition to the standard medical management for septic shock and ARDS. Our case is unique in its atypical initial presentation and highlights the importance of early testing."],"journal":"Am J Nephrol","authors":["Ferrey, Antoney J","Choi, Grace","Hanna, Ramy M","Chang, Yongen","Tantisattamo, Ekamol","Ivaturi, Kaushik","Park, Elisa","Nguyen, Lawrence","Wang, Brian","Tonthat, Sam","Rhee, Connie M","Reddy, Uttam","Lau, Wei Ling","Huang, Susan S","Gohil, Shruti","Amin, Alpesh N","Hsieh, Lanny","Cheng, Timmy T","Lee, Richard A","Kalantar-Zadeh, Kamyar"],"date":"2020-03-31T11:00:00Z","year":2020,"_id":"32222713","week":"202014|Mar 30 - Apr 05","doi":"10.1159/000507417","keywords":["Acute respiratory distress syndrome","End-stage renal disease","Novel coronavirus disease 19","Rennin-angiotensin-aldosterone system blockade","Viral sepsis"],"source":"PubMed","locations":["California","Losartan","US","Utah"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Case Report"],"weight":1,"e_drugs":["tocilizumab","Losartan","Hydroxychloroquine"],"_version_":1663352135214956544,"score":175.23738},{"pmid":32292904,"pmcid":"PMC7103984","title":"Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient.","text":["Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient.","Coronavirus disease 2019 (COVID-19) is a highly infective disease caused by the severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2). Previous studies of the COVID-19 pneumonia outbreak were based on information from the general population. Limited data are available for hemodialysis patients with COVID-19 pneumonia. This report describes the clinical characteristics of COVID-19 in an in-center hemodialysis patient, as well as our experience in implementing steps to prevent the spread of COVID-19 pneumonia among in-center hemodialysis patients. The diagnosis, infection control, and treatment of COVID-19 in hemodialysis patients are discussed in this report, and we conclude with recommendations for how a dialysis facility can respond to COVID-19 based on our experiences.","Kidney Med","Tang, Bin","Li, Sijia","Xiong, Yuwan","Tian, Ming","Yu, Jianbin","Xu, Lixia","Zhang, Li","Li, Zhuo","Ma, Jianchao","Wen, Feng","Feng, Zhonglin","Liang, Xinling","Shi, Wei","Liu, Shuangxin","32292904"],"abstract":["Coronavirus disease 2019 (COVID-19) is a highly infective disease caused by the severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2). Previous studies of the COVID-19 pneumonia outbreak were based on information from the general population. Limited data are available for hemodialysis patients with COVID-19 pneumonia. This report describes the clinical characteristics of COVID-19 in an in-center hemodialysis patient, as well as our experience in implementing steps to prevent the spread of COVID-19 pneumonia among in-center hemodialysis patients. The diagnosis, infection control, and treatment of COVID-19 in hemodialysis patients are discussed in this report, and we conclude with recommendations for how a dialysis facility can respond to COVID-19 based on our experiences."],"journal":"Kidney Med","authors":["Tang, Bin","Li, Sijia","Xiong, Yuwan","Tian, Ming","Yu, Jianbin","Xu, Lixia","Zhang, Li","Li, Zhuo","Ma, Jianchao","Wen, Feng","Feng, Zhonglin","Liang, Xinling","Shi, Wei","Liu, Shuangxin"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292904","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.xkme.2020.03.001","keywords":["coronavirus disease 2019 (covid-19)","epidemic","hemodialysis","lopinavir/ritonavir","severe acute respiratory syndrome coronavirus 2 virus (sars-cov-2)"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664636192473219072,"score":159.86485},{"pmid":32239472,"title":"Proposal of a low-dose, long-pitch, dual-source chest CT protocol on third-generation dual-source CT using a tin filter for spectral shaping at 100 kVp for CoronaVirus Disease 2019 (COVID-19) patients: a feasibility study.","text":["Proposal of a low-dose, long-pitch, dual-source chest CT protocol on third-generation dual-source CT using a tin filter for spectral shaping at 100 kVp for CoronaVirus Disease 2019 (COVID-19) patients: a feasibility study.","AIM: To subjectively and objectively evaluate the feasibility and diagnostic reliability of a low-dose, long-pitch dual-source chest CT protocol on third-generation dual-source CT (DSCT) with spectral shaping at 100Sn kVp for COVID-19 patients. MATERIALS AND METHODS: Patients with COVID-19 and positive swab-test undergoing to a chest CT on third-generation DSCT were included. The imaging protocol included a dual-energy acquisition (HD-DECT, 90/150Sn kVp) and fast, low-dose, long-pitch CT, dual-source scan at 100Sn kVp (LDCT). Subjective (Likert Scales) and objective (signal-to-noise and contrast-to-noise ratios, SNR and CNR) analyses were performed; radiation dose and acquisition times were recorded. Nonparametric tests were used. RESULTS: The median radiation dose was lower for LDCT than HD-DECT (Effective dose, ED: 0.28 mSv vs. 3.28 mSv, p = 0.016). LDCT had median acquisition time of 0.62 s (vs 2.02 s, p = 0.016). SNR and CNR were significantly different in several thoracic structures between HD-DECT and LDCT, with exception of lung parenchyma. Qualitative analysis demonstrated significant reduction in motion artifacts (p = 0.031) with comparable diagnostic reliability between HD-DECT and LDCT. CONCLUSIONS: Ultra-low-dose, dual-source, fast CT protocol provides highly diagnostic images for COVID-19 with potential for reduction in dose and motion artifacts.","Radiol Med","Agostini, Andrea","Floridi, Chiara","Borgheresi, Alessandra","Badaloni, Myriam","Esposto Pirani, Paolo","Terilli, Filippo","Ottaviani, Letizia","Giovagnoni, Andrea","32239472"],"abstract":["AIM: To subjectively and objectively evaluate the feasibility and diagnostic reliability of a low-dose, long-pitch dual-source chest CT protocol on third-generation dual-source CT (DSCT) with spectral shaping at 100Sn kVp for COVID-19 patients. MATERIALS AND METHODS: Patients with COVID-19 and positive swab-test undergoing to a chest CT on third-generation DSCT were included. The imaging protocol included a dual-energy acquisition (HD-DECT, 90/150Sn kVp) and fast, low-dose, long-pitch CT, dual-source scan at 100Sn kVp (LDCT). Subjective (Likert Scales) and objective (signal-to-noise and contrast-to-noise ratios, SNR and CNR) analyses were performed; radiation dose and acquisition times were recorded. Nonparametric tests were used. RESULTS: The median radiation dose was lower for LDCT than HD-DECT (Effective dose, ED: 0.28 mSv vs. 3.28 mSv, p = 0.016). LDCT had median acquisition time of 0.62 s (vs 2.02 s, p = 0.016). SNR and CNR were significantly different in several thoracic structures between HD-DECT and LDCT, with exception of lung parenchyma. Qualitative analysis demonstrated significant reduction in motion artifacts (p = 0.031) with comparable diagnostic reliability between HD-DECT and LDCT. CONCLUSIONS: Ultra-low-dose, dual-source, fast CT protocol provides highly diagnostic images for COVID-19 with potential for reduction in dose and motion artifacts."],"journal":"Radiol Med","authors":["Agostini, Andrea","Floridi, Chiara","Borgheresi, Alessandra","Badaloni, Myriam","Esposto Pirani, Paolo","Terilli, Filippo","Ottaviani, Letizia","Giovagnoni, Andrea"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32239472","week":"202014|Mar 30 - Apr 05","doi":"10.1007/s11547-020-01179-x","keywords":["2019-ncov","covid-19","chest radiology","dual-source ct","low-dose ct","spectral shaping"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["thoracic"],"_version_":1664638354307678208,"score":156.38576}]}